FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Delhivery IPO and Emcure Pharma IPO.
Delhivery IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Delhivery IPO | Emcure Pharma IPO | |
---|---|---|
Logo | ![]() |
![]() |
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Morgan Stanley India Company Pvt Ltd Bofa Securities India Limited Citigroup Global Markets India Private Limited |
Kotak Mahindra Capital Company Limited Axis Capital Limited Jefferies India Private Limited J.P. Morgan India Private Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP ![]() |
DRHP ![]() |
RHP | RHP ![]() |
|
Anchor Investor | Anchor Investor ![]() |
|
IPO Allotment URL | IPO Allotment URL ![]() |
The total issue size of Delhivery IPO is up to ₹5,235.00 Cr whereas the issue size of the Emcure Pharma IPO is . The final issue price of Delhivery IPO is ₹487.00 per share and of Emcure Pharma IPO is .
Delhivery IPO | Emcure Pharma IPO | |
---|---|---|
Face Value | ₹1 per share | ₹10 per share |
Issue Price (Lower) | ₹462.00 per share | |
Issue Price (Upper) | ₹487.00 per share | |
Issue Price (Final) | ₹487.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ₹25.00 per share | |
Market Lot Size | 30 shares | |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹4,000.00 Cr | up to ₹800.00 Cr |
OFS Issue Size | 1,36,78,839 shares | |
OFS Issue Size (Amount) | up to ₹1,235.00 Cr | |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹5,235.00 Cr |
Delhivery IPO opens on May 11, 2022, while Emcure Pharma IPO opens on . The closing date of Delhivery IPO and Emcure Pharma IPO is May 13, 2022, and , respectively.
Delhivery IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | May 11, 2022 | |
Issue Close | May 13, 2022 | |
Basis Of Allotment (Tentative) | May 19, 2022 | |
Initiation of Refunds (Tentative) | May 20, 2022 | |
Credit of Share (Tentative) | May 23, 2022 | |
Listing date (Tentative) | May 24, 2022 | |
Anchor Lockin End date 1 | Jun 18, 2022 | |
Anchor Lockin End date 2 | Aug 17, 2022 |
Delhivery IPO P/E ratio is -67.3, as compared to Emcure Pharma IPO P/E ratio of .
Delhivery IPO | Emcure Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | -67.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹35283.22 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Delhivery IPO retail investors (RII) are offered 1,12,87,878 shares while in Emcure Pharma IPO retail investors are offered 1,12,87,878 shares. Qualified institutional buyers (QIB) are offered 3,38,63,662 shares in Delhivery IPO and in Emcure Pharma IPO.
Delhivery IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 3,38,63,662 shares | |
NII | 1,69,31,818 shares | |
RII | 1,12,87,878 shares | |
Employee | 4,57,665 shares | |
Others | ||
Total | 6,25,41,023 shares |
Delhivery IPO subscribed 1.63x in total, whereas Emcure Pharma IPO subscribed .
Delhivery IPO | Emcure Pharma IPO | |
---|---|---|
QIB (times) | 2.66x | |
NII (times) | 0.30x | |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 0.57x | |
Employee (times) | 0.27x | |
Other (times) | 0.00x | |
Total (times) | 1.63x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|